Together, the expanding arsenal of mTOR inhibitors, which are capable of targeting different branches of mTOR signaling, either alone or in combination with genotoxic agents or immunotherapies, represents a powerful toolkit for the treatment of cancer and other diseases. This evidence concerns the gene MTOR and cancer.